Literature DB >> 24240584

Positive association between vascular endothelial growth factor (VEGF) -2578 C/A variant and prostate cancer.

M L Martinez-Fierro1, I Garza-Veloz, A Rojas-Martinez, R Ortiz-Lopez, C Castruita-de la Rosa, Y Ortiz-Castro, B P Lazalde-Ramos, A R Cervantes-Villagrana, M E Castañeda-Lopez, L Gomez-Guerra, I Delgado-Enciso, A A Martinez-Torres.   

Abstract

BACKGROUND: Vascular endothelial growth factor (VEGF) gene is an important angiogenesis regulator related to cancer development and progression. We evaluated the association between -2578 C/A (rs699947) VEGF polymorphism and PCa in Mexican subjects, to contribute to knowledge of VEGF role in genetic epidemiology of prostate cancer (PCa).
OBJECTIVE: The aim of this study was to evaluate the association between -2578 C/A VEGF variant and PCa in Mexican population.
METHODS: A total of 249 men (77 PCa cases and 172 controls) from the Northwestern region of Mexico were screened for the -2578 C/A VEGF variant. The polymorphism was determined by polymerase chain reaction-based restriction analysis.
RESULTS: Genotype frequencies for C/C, C/A, and A/A, were 0.48, 0.49, 0.03 for cases and 0.41, 0.45, 0.14 for controls respectively. Genotype A/A of -2578 VEGF variant reduces the risk of PCa in an 84% among studied population (Odds Ratio 0.16; 95% CI: 0.04-0.71, P=0.007). C/C carriers showed an increased PCa risk of 6.1 times among the study population.
CONCLUSIONS: Inheritance of -2578 A/A genotype of VEGF gene may modify PCa susceptibility risk in Mexican population.

Entities:  

Keywords:  Prostate cancer; VEGF; genetic susceptibility; polymorphism

Mesh:

Substances:

Year:  2013        PMID: 24240584     DOI: 10.3233/CBM-130348

Source DB:  PubMed          Journal:  Cancer Biomark        ISSN: 1574-0153            Impact factor:   4.388


  9 in total

1.  Role of five small nucleotide polymorphisms in the VEGF gene on the susceptibility to osteosarcoma and overall survival of patients.

Authors:  Jian-Qiang Liu; Xia Bai; DE-Chen Duan; Ai-Xia Dou
Journal:  Oncol Lett       Date:  2015-06-19       Impact factor: 2.967

2.  Haplotype-based association of Vascular Endothelial Growth Factor gene polymorphisms with urothelial bladder cancer risk in Tunisian population.

Authors:  Safa Ben Wafi; Amani Kallel; Mohamed Kacem Ben Fradj; Ahmed Sallemi; Sami Ben Rhouma; Meriam Ben Halima; Haifa Sanhaji; Yassine Nouira; Riadh Jemaa; Moncef Feki
Journal:  J Clin Lab Anal       Date:  2018-06-29       Impact factor: 2.352

3.  Predictive value of vascular endothelial growth factor polymorphisms on the risk of renal cell carcinomas: a case-control study.

Authors:  Guangjian Lu; Yuqian Dong; Qunmei Zhang; Luyang Jiao; Shujuan Yang; Beili Shen
Journal:  Tumour Biol       Date:  2015-06-05

4.  Association of the vascular endothelial growth factor -2578C/A polymorphism with cancer risk: A meta-analysis update.

Authors:  Quanchi Chen; Zifei Zhou; Liangcheng Shan; Yingqi Hua; Hui Zeng; Pengcheng Liu; Zhengdong Cai
Journal:  Biomed Rep       Date:  2014-07-15

5.  VEGF +405G/C (rs2010963) polymorphisms and digestive system cancer risk: a meta-analysis.

Authors:  Qing Guo; Sheng-Bin Dai; Feng Shen; Di Yu; Shu-Tong Shen; Qu Zhang; Jun-Xing Huang; Zheng-Dong Wu
Journal:  Tumour Biol       Date:  2014-01-29

6.  Predictive value of vascular endothelial growth factor polymorphisms on the clinical outcome of renal cell carcinoma patients.

Authors:  Nan Ma; Li-Wei Li; Jing-Liang Cheng
Journal:  Oncol Lett       Date:  2014-12-12       Impact factor: 2.967

7.  Vascular Endothelial Growth Factor (VEGF) Gene Promoter Polymorphisms and Disease Progression in North Indian Cohort with Autosomal Dominant Polycystic Kidney Disease.

Authors:  Shewata Pandita; Deepshikha Maurya; Vijaya Ramachandran; Jyotsna Verma; Sudha Kohli; Renu Saxena; Ishwar Chander Verma
Journal:  Int J Mol Cell Med       Date:  2017-09-26

8.  Association Between 12 Polymorphisms of VEGF/Hypoxia/Angiogenesis Pathway Genes and Risk of Urogenital Carcinomas: A Meta-Analysis Based on Case-Control Studies.

Authors:  Jin-Bo Chen; Meng Zhang; Yu Cui; Pei-Hua Liu; Yan-Wei Qi; Chao Li; Xu Cheng; Wen-Biao Ren; Qia-Qia Li; Long-Fei Liu; Min-Feng Chen; He-Qun Chen; Xiong-Bing Zu
Journal:  Front Physiol       Date:  2018-06-11       Impact factor: 4.566

9.  Joint Effect of Urinary Total Arsenic Level and VEGF-A Genetic Polymorphisms on the Recurrence of Renal Cell Carcinoma.

Authors:  Shu-Mei Yang; Chao-Yuan Huang; Horng-Sheng Shiue; Shu-Pin Huang; Yeong-Shiau Pu; Wei-Jen Chen; Ying-Chin Lin; Yu-Mei Hsueh
Journal:  PLoS One       Date:  2015-12-23       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.